As a national specialized and new "little giant" enterprise focusing on medical technology innovation, the core product "Intelligent Chromosome Scanning and Analysis System" has won a number of industry honors once it was launched, creating a new era of AI chromosome karyotype analysis. A few days ago, at the 2024 Ecological Partner Conference, Deshi Biotech launched an integrated equipment for cytogenetic pretreatment assembly line, which has since realized the product line covering the whole process of cytogenetic testing. At the same time, four major solutions for the prenatal diagnosis industry, assisted reproduction industry, blood disease testing industry and radiation occupational disease prevention and treatment industry were released at the meeting, aiming to empower these four industries and improve their detection and diagnosis efficiency.
Prenatal diagnostic industry solutions
In the context of the "three-child" policy, the childbearing age has been further extended and gradually showing an aging trend, and the problem of birth defects has become increasingly prominent. Karyotype analysis is the "gold standard" of genetic diagnosis, which runs through the birth defect prevention and control system, and has important clinical value in the prenatal diagnosis industry. However, the traditional karyotype analysis technology has a low degree of intelligence, high human consumption, low efficiency, and long report issuance time, which seriously affects the accuracy, timeliness and popularity of prenatal diagnosis, and cannot meet the growing market demand for prenatal testing.
Based on the self-developed Kayoflow cytogenetic pretreatment line integrated equipment, Metasight G200 automatic cell microscopic scanning system, AutoVision intelligent chromosome karyotype analysis system and cytogenetic reagents, Deshi Biotech provides an industry-wide one-stop solution for the field of prenatal diagnosis, which greatly improves the efficiency and accuracy of prenatal diagnosis and helps healthy fertility.
Assisted reproduction industry solutions
In addition to birth defects, infertility is also a major obstacle to healthy fertility. Although assisted reproductive technology has been around for a long time, the complexity and high cost of the technology also restrict the development of this industry. Since its establishment, Deshi Biotech has been based on product research and development in the field of healthy fertility, among which the innovative research and development of ICSI microinjection needles and holding fallopian tubes have broken the monopoly of foreign technology, effectively improved the accuracy of assisted reproduction experiments, fully realized the domestic substitution of core products, and greatly reduced the cost of assisted reproduction.
Assisted reproductive technology** is usually preceded by a thorough genetic test. The AI chromosome karyotype scanning and analysis system independently developed by Deshi Biotech, combined with whole genome optical mapping (OGM) technology, can provide patients with full-coverage cytogenetic testing and provide all-round guarantee for the smooth development of assisted reproduction.
This set of industry solutions covers the whole process of assisted reproductive testing, effectively improving the accuracy of assisted reproductive technology, helping assisted reproductive technology to further popularize, and helping more families achieve healthy childbirth.
Hematology testing industry solutions
In the field of hematological disease testing, due to the complexity of hematological diseases, the screening work is very complex. Focusing on the screening of hematological diseases, relying on the self-developed Kayoflow cytogenetic pretreatment line integrated equipment, Metasight G200 automatic cell microscopy scanning system and AutoVision intelligent chromosome karyotype analysis system and other products, with whole genome optical mapping (OGM) technology, it provides the industry with efficient and integrated auxiliary diagnostic tools to help clinicians detect blood diseases more quickly and accurately , so that patients can get accurate and effective ** in a timely manner, and improve the likelihood of recovery.
Radiation occupational disease prevention and control industry solutions
In the radiation occupational disease prevention and treatment industry, Deshi Biotech has also launched industry solutions. For the occupational health examination of radiological workers, the difference from other industries is that this solution includes technologies such as intelligent micronucleus analysis and intelligent chromosomal aberration analysis, and uses AI algorithms to help the detection of occupational diseases be more intelligent, accurate and efficient. The value of this program is not only to improve the efficiency of medical work, but also to protect the health line of defense for special occupational groups, help prevent the occurrence of occupational diseases in advance, and also provide scientific and technological support for the prevention and treatment of occupational diseases.
From the research of prenatal diagnosis and assisted reproduction, to the screening of blood diseases, to the prevention and treatment of radiation occupational diseases, Deshi Biotech has given efficient and collaborative solutions. The release of the four major industry solutions demonstrates the technical strength of Deshi Biotech in the field of biomedicine, demonstrates that its scientific research results have wide application value in actual clinical species, and contributes to the realization of the grand goal of "Healthy China 2030".